PRESS RELEASE published on 09/11/2024 at 15:08, 1 year 11 months ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.12% stake in SEGRO plc as of 10 September 2024. Purchase of 3,724 shares at 8.91 GBP per unit The Vanguard Group Financial Disclosure Share Purchase Stake Disclosure SEGRO PLC
PRESS RELEASE published on 09/11/2024 at 15:07, 1 year 11 months ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc The Vanguard Group, Inc. files Form 8.3 for Hargreaves Lansdown plc disclosing 3.93% ownership, with 18,636,155 relevant securities held Form 8.3 Relevant Securities Vanguard Group Ownership Disclosure Hargreaves Lansdown Plc
PRESS RELEASE published on 09/11/2024 at 15:06, 1 year 11 months ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses 4.90% interest in Smith (DS) plc. Public opening position disclosure as per Rule 8.3 of the Takeover Code The Vanguard Group, Inc. Disclosure Rule 8.3 Smith (DS) Plc Interests
PRESS RELEASE published on 09/11/2024 at 15:05, 1 year 11 months ago Form 8.3 - The Vanguard Group, Inc.: REA Group Ltd The Vanguard Group, Inc. discloses a 2.08% ownership in REA Group Ltd as of 10th Sept 2024, partaking in dealings with Rightmove plc The Vanguard Group Ownership Disclosure Dealings Rightmove Plc REA Group Ltd
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago Director/PDMR Shareholding easyJet plc notified on 11 Sep 2024 of director share purchases under Share Incentive Plan. PDMRs bought 31 shares each at £4.87 PDMR Share Incentive Plan Shareholding EasyJet Plc Director
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago FTSE Russell US Wealth Survey Results FTSE Russell US Wealth survey reveals US investors cautious due to economy & election, empowered by index funds & advisors. Majority believe election impacts finances but only 21% adjusting portfolios Financial Advisors US Investors FTSE Russell Index Funds Election Impact
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago Xenetic Biosciences, Inc. Presents at the H.C. Wainwright 26th Annual Global Investment Conference Xenetic Biosciences presented at H.C. Wainwright 26th Annual Global Investment Conference. The biopharmaceutical company focuses on immune-oncology technologies for hard-to-treat cancers Xenetic Biosciences Biopharmaceutical Immune-oncology JTC Team Cancers
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago Visual Edge IT Brings Technology Solutions to the Printing Industry Meet a Pro Football Hall of Famer at Visual Edge IT booth to raise awareness for cybersecurity in the printing industry. Get a security assessment to prevent financial risks Cybersecurity Printing Industry Security Assessment Visual Edge IT Pro Football Hall Of Famer
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago Applied DNA Launches Mpox Clade I and Clade II Testing Service Applied DNA Sciences expands clinical testing to include detection of Mpox Clade I and Clade II. ADCL, a NYSDOH CLEP-permitted laboratory, offers Linea Mpox Virus 1.0 Assay from Stony Brook, NY Applied DNA Sciences Linea Mpox Virus 1.0 Assay Mpox Testing ADCL Clinical Laboratory
PRESS RELEASE published on 09/11/2024 at 14:39, 1 year 11 months ago Edison issues report on Partners Group Private Equity (PEY/PEYS) Edison issues report on Partners Group Private Equity, highlighting successful realisation proceeds and strong performance indicators. Click for full report Edison Investment Performance Realisation Proceeds Partners Group Private Equity Exit Candidates
Published on 09/05/2026 at 04:05, 2 days 4 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 9 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 9 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 10 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 2 days 18 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/07/2026 at 08:20, 26 minutes ago 63% WO₃: San Juan tungsten confirms commercial-grade concentrates
Published on 09/07/2026 at 08:00, 46 minutes ago £175m first close of Molten Ventures Growth Fund with cornerstone commitment from British Business Bank
Published on 09/04/2026 at 18:57, 2 days 13 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 2 days 15 hours ago Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 16:00, 2 days 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 2 days 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
